Successful evaluation of cognitive function and the nature of cognitive deficits among people with schizophrenia in clinical rehabilitation settings

John, Alexander; Yeak, Kim; Ayres, Helen; Sevastos, Marie; Moore, Elizabeth

doi:10.1177/1039856216656537

Cited by 3 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We evaluated cognitive function using a standardized instrument, which measures various domains of cognition affected in people with schizophrenia. Although the MATRICS Consensus Cognitive Battery is considered to be the gold standard for evaluation of cognitive function in schizophrenia (Kern et al, 2008; Nuechterlein et al, 2008), in ordinary clinical practice, brief assessments of cognitive functions are often more feasible and are as reliable and valid as lengthy neuropsychological tests (Fervaha et al, 2015; John et al, 2016; Keefe et al, 2004, 2008).…”

Section: Discussionmentioning

confidence: 99%

“…The Brief Assessment of Cognition in Schizophrenia (BACS; Keefe et al, 2004Keefe et al, , 2008 was used to evaluate cognitive functioning. This paper-and-pencil cognitive assessment instrument, which takes approximately 35 min to administer, has sound psychometric properties (Keefe et al, 2008) and is feasible to be administered in clinical rehabilitation settings (John, Yeak, Ayres, Sevastos, & Moore, 2016). The six subtests of the BACS include verbal memory (VM) digit sequencing (DS), token motor task (TMT), verbal fluency (VF), symbol coding (SC), and Tower of London (ToL).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Successful implementation of a cognitive remediation program in everyday clinical practice for individuals living with schizophrenia.

John

Yeak²,

Ayres

et al. 2017

Psychiatric Rehabilitation Journal

Self Cite

View full text Add to dashboard Cite

Cognitive remediation interventions were accepted by a sizable proportion of people with schizophrenia admitted to an inpatient clinical treatment and rehabilitation facility. Promising improvement in cognitive function among those who completed the training suggests the need for methodologically rigorous research exploring the feasibility and benefits of cognitive remediation programs at everyday clinical settings. (PsycINFO Database Record

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Successful implementation of a cognitive remediation program in everyday clinical practice for individuals living with schizophrenia.

John

Yeak²,

Ayres

et al. 2017

Psychiatric Rehabilitation Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…According to a systematic review conducted in 2014 [ 105 ], the MCCB was the instrument adopted in most trials ( N = 69), followed by the BACS ( N = 24). In addition, the BACS has proven to be a feasible tool in a clinical rehabilitation setting [ 147 ]; however, more research is advisable. BNA and B-CATS were not used in any clinical trial.…”

Section: Instruments Developed For Assessing Neurocognitive Impairmen...mentioning

confidence: 99%

European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia

et al. 2022

View full text Add to dashboard Cite

Background Impairment in a wide range of cognitive abilities has been consistently reported in individuals with schizophrenia. Both neurocognitive and social cognitive deficits are thought to underlie severe functional disabilities associated with schizophrenia. Despite the key role in schizophrenia outcome, cognition is still poorly assessed in both research and clinical settings. Methods In this guidance paper, we provide a systematic review of the scientific literature and elaborate several recommendations for the assessment of cognitive functions in schizophrenia both in research settings and in real-world clinical practice. Results Expert consensus and systematic reviews provided guidance for the optimal assessment of cognitive functions in schizophrenia. Based on the reviewed evidence, we recommend a comprehensive and systematic assessment of neurocognitive and social cognitive domains in schizophrenia, in all phases of the disorder, as well as in subjects at risk to develop psychosis. This European Psychiatric Association guidance recommends not only the use of observer reports but also self-reports and interview-based cognitive assessment tools. The guidance also provides a systematic review of the state of the art of assessment in the first episode of psychosis patients and in individuals at risk for psychosis. Conclusion The comprehensive review of the evidence and the recommendations might contribute to advance the field, allowing a better cognitive assessment, and avoiding overlaps with other psychopathological dimensions. The dissemination of this guidance paper may promote the development of shared guidelines concerning the assessment of cognitive functions in schizophrenia, with the purpose to improve the quality of care and to obtain recovery.

show abstract

“…Значительное количество работ, посвященных поискам коррелятов СФ пациентов, сосредоточено вокруг оценки нейрокогнитивного дефицита. В таких исследованиях было установлено, что позитивные симптомы шизофрении не связаны с когнитивным дефицитом [36], однако, были обнаружены существенные связи между негативными симптомами и дефицитом памяти, беглостью речи, исполнительными функциями и скоростью обработки информации [21]. На данный момент общепринятой является точка зрения, согласно которой дефицит когнитивного функционирования при шизофрении носит преимущественно генерализованный, гетерогенный характер, однако, наибольшая его выраженность проявляется в следующем ряде функций: эпизодическая память; скорость обработки информации; вербальная беглость; внимание; исполнительные функции; рабочая память [37; 2].…”

unclassified

The metacognitive functioning of patients with paranoid schizophrenia through the prism of emotional intelligence: a connection with cognitive deficit, clinical manifestations, social functioning and quality of life

Sofronov¹,

Trusova

Гетманенко

et al. 2020

V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY

View full text Add to dashboard Cite

Metacognitive functioning is the basis of the individual’s ideas about his ability to build relationships with other people and manage own’s social behavior. Deterioration of metacognitive functioning in schizophrenia patients, presumably due to neurocognitive deficiency and other manifestations of the disease, probably contributes to disruptions of social functioning and quality of life. The aim of this study was to assess the metacognitive functioning (MF) of patients with paranoid schizophrenia, operationalized as a cognitive ability to understand their own and other people’s emotions, and to explore the connection between social functioning (SF) and quality of life (QOL), as well as to establish logical relationships between MF with clinical indicators and socio-demographic characteristics of patients. In a sample of 300 patients with paranoid schizophrenia (age from 18 to 50 years, disease duration of at least 5 years, a total PANSS score of less than 120), MF was assessed using the Lyusin emotional intelligence test (EmIn) and the subjective assessment of interpersonal relationships (SOMO) test. Cognitive deficit was verified using a standardized battery of a Brief Assessment of Cognition in Schizophrenia (BACS). The indicators obtained using the quality of life questionnaire for schizophrenia patients (QOL-SM) and the social functioning scale (PSP) were used to create an integrated indicator that comprehensively assesses SF and QOL of schizophrenia patients (Factor B). Reliable associations of this factor with indicators obtained using the Emin method (p<0.05), SOMO (p<0.001), the PSP scale, the QOL-SM questionnaire, the BACS and PANSS scales, and also with a number of clinical-dynamic and socio-demographic characteristics were established. Significant relationships between the parameters of MF, SF and QOL were obtained, and logical relationships between MF, neurocognitive deficiency and other clinical manifestations of schizophrenia were established.

show abstract

Successful evaluation of cognitive function and the nature of cognitive deficits among people with schizophrenia in clinical rehabilitation settings

Cited by 3 publications

References 17 publications

Successful implementation of a cognitive remediation program in everyday clinical practice for individuals living with schizophrenia.

Successful implementation of a cognitive remediation program in everyday clinical practice for individuals living with schizophrenia.

European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia

The metacognitive functioning of patients with paranoid schizophrenia through the prism of emotional intelligence: a connection with cognitive deficit, clinical manifestations, social functioning and quality of life

Contact Info

Product

Resources

About